BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 1320152)

  • 1. Enrofloxacin treatment of long-tailed macaques with acute bacillary dysentery due to multiresistant Shigella flexneri IV.
    Line AS; Paul-Murphy J; Aucoin DP; Hirsh DC
    Lab Anim Sci; 1992 Jun; 42(3):240-4. PubMed ID: 1320152
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lack of reactivation of shigellosis in naturally infected enrofloxacin-treated cynomolgus monkeys after exogenous immunosuppression.
    Black-Schultz L; Coatney RW; Warnick CL; Swif B
    Lab Anim Sci; 1997 Dec; 47(6):602-5. PubMed ID: 9433696
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clearance of Shigella flexneri carriers in a zoologic collection of primates.
    Banish LD; Sims R; Bush M; Sack D; Montali RJ
    J Am Vet Med Assoc; 1993 Jul; 203(1):133-6. PubMed ID: 8407447
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Control of Shigella flexneri in Celebes black macaques (Macaca nigra).
    Olson LC; Bergquist DY; Fitzgerald DL
    Lab Anim Sci; 1986 Jun; 36(3):240-2. PubMed ID: 3523037
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Toxic food infection caused by Shigella flexneri in a military unit].
    Cheftel E; Spiegel A; Bornert G; Morell E; Michel A; Buisson Y
    Sante; 1997; 7(5):295-9. PubMed ID: 9480034
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Observations on shigellosis and development of multiply resistant Shigellas in Macaca mulatta.
    Lindsey JR; Hardy PH; Baker HJ; Melby EC
    Lab Anim Sci; 1971 Dec; 21(6):832-44. PubMed ID: 4332152
    [No Abstract]   [Full Text] [Related]  

  • 7. Distribution and antibiotic susceptibility of Shigella isolates in Bangui, Central African Republic.
    Bercion R; Njuimo SP; Boudjeka PM; Manirakiza A
    Trop Med Int Health; 2008 Apr; 13(4):468-71. PubMed ID: 18282240
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of fluoroquinolone-resistant Shigella flexneri in Hangzhou area of China.
    Pu XY; Pan JC; Wang HQ; Zhang W; Huang ZC; Gu YM
    J Antimicrob Chemother; 2009 May; 63(5):917-20. PubMed ID: 19297378
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A pharmacokinetic study of enrofloxacin and its active metabolite ciprofloxacin after oral and intramuscular dosing of enrofloxacin in rhesus monkeys (Macaca mulatta).
    Klein H; Hasselschwert D; Handt L; Kastello M
    J Med Primatol; 2008 Aug; 37(4):177-83. PubMed ID: 18384536
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transferable multiple drug resistance in enterobacteria from non-human primates. I. Development and characteristics of resistance in Shigella Flexneri.
    Hardy PH; Lindsey JR; Melby EC
    Johns Hopkins Med J; 1968 Jul; 123(1):29-37. PubMed ID: 5667656
    [No Abstract]   [Full Text] [Related]  

  • 11. Bacterial enteric pathogens in children with acute dysentery in Thailand: increasing importance of quinolone-resistant Campylobacter.
    Bodhidatta L; Vithayasai N; Eimpokalarp B; Pitarangsi C; Serichantalergs O; Isenbarger DW
    Southeast Asian J Trop Med Public Health; 2002 Dec; 33(4):752-7. PubMed ID: 12757222
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Shigella infection rate in imported cynomolgus monkeys and drug-sensitivity of the isolates.
    Takasaka M; Honjo S; Imaizumi K
    Jikken Dobutsu; 1973; 22 Suppl(0):377-87. PubMed ID: 4807726
    [No Abstract]   [Full Text] [Related]  

  • 13. Shigella isolates of Nepal: changes in the incidence of shigella subgroups and trends of antimicrobial susceptibility pattern.
    Kansakar P; Malla S; Ghimire GR
    Kathmandu Univ Med J (KUMJ); 2007; 5(1):32-7. PubMed ID: 18603983
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Resistance to fluoroquinolones by the combination of target site mutations and enhanced expression of genes for efflux pumps in Shigella flexneri and Shigella sonnei strains isolated in Korea.
    Kim JY; Kim SH; Jeon SM; Park MS; Rhie HG; Lee BK
    Clin Microbiol Infect; 2008 Aug; 14(8):760-5. PubMed ID: 18727800
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma concentrations of enrofloxacin and its active metabolite ciprofloxacin in dogs following single oral administration of enrofloxacin at 7.5, 10, or 20 mg/kg.
    Boothe DM; Boeckh A; Boothe HW; Wilkie S; Jones S
    Vet Ther; 2002; 3(4):409-19. PubMed ID: 12584678
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of enrofloxacin on digoxin clearance and steady-state serum concentrations in dogs.
    Novotny MJ; Shaw DH
    Can J Vet Res; 1991 Apr; 55(2):113-6. PubMed ID: 1884291
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Characteristics of the Shigella flexneri strains isolated from Japanese monkeys (Macaca fuscata)].
    Chida T; Okamura N; Taniguchi H; Hondo R
    Kansenshogaku Zasshi; 1993 Jun; 67(6):524-7. PubMed ID: 8336006
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetic properties of enrofloxacin in rabbits.
    Broome RL; Brooks DL; Babish JG; Copeland DD; Conzelman GM
    Am J Vet Res; 1991 Nov; 52(11):1835-41. PubMed ID: 1664673
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics of enrofloxacin and its metabolite ciprofloxacin after intravenous and intramuscular administrations in sheep.
    Mengozzi G; Intorre L; Bertini S; Soldani G
    Am J Vet Res; 1996 Jul; 57(7):1040-3. PubMed ID: 8807018
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetic evaluation of enrofloxacin administered orally to healthy dogs.
    Walker RD; Stein GE; Hauptman JG; MacDonald KH
    Am J Vet Res; 1992 Dec; 53(12):2315-9. PubMed ID: 1335707
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.